Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Abstract
Excess free iron generates oxidative stress that hallmarks diseases of aging. The observation that patients with Alzheimer's disease or Parkinson's disease show a dramatic increase in their brain iron content has opened the possibility that disturbances in brain iron homeostasis may contribute to the pathogenesis of these disorders. While the reason for iron accumulation is unknown, iron localization correlates with the production of reactive oxygen species in those areas of the brain that are prone to neurodegeneration. A role for iron is also proposed in atherosclerosis, a further frequent disorder of aging. We will review experimental evidences for an involvement of iron in these diseases and discuss some mouse models with impairment in iron-related genes that may be useful to study the role of iron in these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Iron chelation improves endothelial function”
From Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (2010) · cites this paper as Altamura and Muckenthaler 2009
In the citing paper
“Excessive amounts of total iron will decrease furin activity because transcription of furin is modulated by cellular concentrations of iron, leading to decreased furin protein concentrations which thereby favours β secretase activity and enhances the amyloidogenic pathway.”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
In the citing paper
“By contrast, iron deficiency will increase furin activity, thereby enhancing α secretase and stimulating the non-amyloidogenic pathway.78,80”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
In the citing paper
“APP translation might therefore be up-regulated in conditions of iron excess, increasing the amount of APP available to enter the amyloidgenic pathway, which is favoured by decreased furin activity.78”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [78]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630 · cited 1×
“Atherosclerosis can be initiated by the injury of endothelial cells of the arterial wall that leads to enhanced permeability [121].”
BackgroundMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Primate models of movement disorders of basal ganglia origin
DeLong, M. R. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90110-v · Cited by 3,824
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786 · cited 1×
“In 96% of cases, it is caused by a GAA nucleotide repeat expansion inside the first intron of the frataxin gene resulting in reduced frataxin mRNA expression [183].”
Background
Cited by
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Oxidative stress in Alzheimer’s disease
Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1423-y · Cited by 797
“Iron accumulation is also present in cells associated with neuritic plaques in AD([75]), which results in the increase of oxidative stress.”
BackgroundBioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
“Conditions such as neuroferritinopathy [217] and Friedreich ataxia are associated with mutations in genes that encode proteins involved in iron metabolism [218], inducing OS and cell death [441] the brain ages, iron accumulates in regions that are affected by AD and PD [219], and dopamine (DA) complexes of iron are im…”
BackgroundQuantitative MR Imaging of Brain Iron: A Postmortem Validation Study
Langkammer, C., Krebs, N., Goessler, W., Scheurer, E., Ebner, F., Yen, K., Fazekas, F., & Ropele, S. (2010) · Radiology · doi:10.1148/radiol.10100495 · Cited by 507
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
“A role for iron is also proposed in atherosclerosis, a frequent disorder of aging (17).”
Hydroxyl Radical and Its Scavengers in Health and Disease
Lipinski, B. (2011) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2011/809696 · Cited by 456
“In connection with this, it is of importance to note that excessive accumulation of stored iron is observed in atherosclerotic lesion [15] as well as in brains patients with neurological diseases [16].”
BackgroundCurrent understanding of metal ions in the pathogenesis of Alzheimer’s disease
Wang, L., Yin, Y.-L., Liu, X.-Z., Shen, P., Zheng, Y.-G., Lan, X.-R., Lu, C.-B., & Wang, J.-Z. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00189-z · Cited by 454
“In the presence of elevated iron, increased synaptic activity can cause iron overload which concurs to the cytotoxic effects, as seen in early stage of AD patients [119].”
BackgroundTargeting the transferrin receptor for brain drug delivery
Johnsen, K. B., Burkhart, A., Thomsen, L. B., Andresen, T. L., & Moos, T. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101665 · Cited by 370
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…of iron in these processes: • Both iron and oxidised lipids (de Valk and Marx 1999; Smith et al. 1992) are found in atherosclerotic lesions (Altamura and Muckenthaler 2009; Brewer 2007; Chau 2000; Fernandes de Godoy et al. 2007; Gajda et al. 2008; Halliwell 2009; Horwitz et al. 1998;…”
BackgroundInfluentialGlutathione revisited: a vital function in iron metabolism and ancillary role in thiol‐redox control
Kumar, C., Igbaria, A., D'Autreaux, B., Planson, A., Junot, C., Godat, E., Bachhawat, A. K., Delaunay‐Moisan, A., & Toledano, M. B. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.105 · Cited by 323
“…to elucidating the intricate pathophysiological links between redox imbalance, GSH depletion, alterations of iron metabolism and oxidative stress underlying age-related diseases, such as neurodegeneration and inflammation (Altamura and Muckenthaler, 2009; Bharath et al, 2002; Lee et al, 2009).”
BackgroundOxidative stress and metal carcinogenesis
Lee, J.-C., Son, Y.-O., Pratheeshkumar, P., & Shi, X. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.002 · Cited by 275
“In addition, Fe metabolism is involved in the etiology of hypertension, atherosclerosis, neurodegenerative disorders, and rheumatoid arthritis [167,168].”
BackgroundRecent advances in our understanding of neurodegeneration
Jellinger, K. A. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0240-y · Cited by 274
“…2005) and Friedreich ataxia (FRDA) are associated with mutations in genes that encode proteins involved in iron metabolism, and as the brain ages, iron accumulates in regions that are affected by AD and PD (Altamura and Muckenthaler 2009; Gerlach et al. 2006; Linert et al. 2006; Zecca et al. 2004).”
BackgroundRaven, E. P., Lu, P. H., Tishler, T. A., Heydari, P., & Bartzokis, G. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130209 · Cited by 270
“brain is especially vulnerable (for review, see [1–5]).”
Iron Metabolism, Ferroptosis, and the Links With Alzheimer’s Disease
Yan, N., & Zhang, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01443 · Cited by 251
“Iron depositions in the specific brain regions have been proved in AD through imaging and histologic examinations (Altamura and Muckenthaler, 2009; Mills et al., 2010; Apostolakis and Kypraiou, 2017; Lee and Lee, 2019).”
BackgroundBrain iron metabolism and its perturbation in neurological diseases
Crichton, R. R., Dexter, D. T., & Ward, R. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0470-z · Cited by 248
Zhou, Z. D., & Tan, E.-K. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0218-4 · Cited by 222
“ance of the IRP-IRE signaling pathway [46, 47].”
Vascular aspects of multiple sclerosis
D'haeseleer, M., Cambron, M., Vanopdenbosch, L., & De Keyser, J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70105-3 · Cited by 241
Transition metal homeostasis: from yeast to human disease
Bleackley, M. R., & MacGillivray, R. T. A. (2011) · BioMetals · doi:10.1007/s10534-011-9451-4 · Cited by 231
“A dramatic increase in brain iron levels has been observed in both Parkinson’s and Alzheimer’s disease patients, and is thought to mediate neurodegeneration through the production of reactive oxygen species (Altamura and Muckenthaler 2009).”
BackgroundThe role of free radicals in the aging brain and Parkinson’s Disease: Convergence and parallelism
Kumar, H., Lim, H.-W., More, S. V., Kim, B.-W., Koppula, S., Kim, I. S., & Choi, D.-K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810478 · Cited by 212
“H2O2, and iron localization correlates with ROS in areas that are prone to neurodegeneration [165].”
BackgroundSingh, N., Haldar, S., Tripathi, A. K., Horback, K., Wong, J., Sharma, D., Beserra, A., Suda, S., Anbalagan, C., Dev, S., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4931 · Cited by 208
“The correlation between brain iron metabolism and neurotoxicity associated with neurodegenerative conditions such as AD, PD, HD, and sCJD remains controversial (13).”
Anomalous Venous Blood Flow and Iron Deposition in Multiple Sclerosis
Singh, A. V., & Zamboni, P. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.180 · Cited by 202
“The role of metallobiology in neurodegenerative disorders has long been implicated, with particular attention given to iron as it is one of the most important redox metals, which have been largely linked to senile toxicity and neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases and aging patients…”
BackgroundTargeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
Weinreb, O., Mandel, S., Youdim, M. B. H., & Amit, T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.017 · Cited by 190
Out of Balance—Systemic Iron Homeostasis in Iron-Related Disorders
Steinbicker, A., & Muckenthaler, M. (2013) · Nutrients · doi:10.3390/nu5083034 · Cited by 195
“iron homeostasis may contribute to the pathogenesis of these disorders [164–166].”
BackgroundSelf-citationmTOR regulates cellular iron homeostasis through tristetraprolin
Bayeva, M., Khechaduri, A., Puig, S., Chang, H.-C., Patial, S., Blackshear, P. J., & Ardehali, H. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.001 · Cited by 197
“Thus, iron levels must be tightly controlled at both cellular and systemic levels and deregulation of iron homeostasis is associated with aging, metabolic disorders and cancer (Aisen et al., 2001; Altamura and Muckenthaler, 2009; Torti and Torti, 2011; Weinberg, 2010).”
BackgroundMitochondrial iron metabolism and its role in neurodegeneration
Horowitz, M. P., & Greenamyre, J. T. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100354 · Cited by 195
“While some researchers have proposed that iron-binding by Aβ is a protective response to sequester iron and prevent the development of oxidative stress [79], iron binding has also been shown to promote Aβ aggregation and neurotoxicity [77,80].”
Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
von Bernhardi, R., & Eugenín, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 190
“Strong evidence indicates that dyshomeostasis of redox-active biometals, copper (Cu) and Fe, and oxidative stress contribute to the neuropathology of AD (12).”
BackgroundBrain Iron Metabolism Dysfunction in Parkinson’s Disease
Jiang, H., Wang, J., Rogers, J., & Xie, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9879-1 · Cited by 180
Iron uptake and transport across physiological barriers
Duck, K. A., & Connor, J. R. (2016) · BioMetals · doi:10.1007/s10534-016-9952-2 · Cited by 173
“…may increase risk or alter the course of many neurodegenerative diseases it became important to understand how the HFE protein is functioning to modulate iron transport at the brain but also other physiological barriers (Altamura and Muckenthaler 2009; Loeffler et al. 1995; Zecca et al. 2004).”
BackgroundInflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)—New Aspects
Baum, P., Toyka, K. V., Blüher, M., Kosacka, J., & Nowicki, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910835 · Cited by 209
Letelier, M. E., Sánchez-Jofré, S., Peredo-Silva, L., Cortés-Troncoso, J., & Aracena-Parks, P. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.06.013 · Cited by 168
Iron and the pathophysiology of diabetes
Harrison, A. V., Lorenzo, F. R., & McClain, D. A. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022522-102832 · Cited by 161
“• High iron is associated with not only T2DM but also nonalcoholic steatohepatitis (NASH) (7), Parkinson’s and Alzheimer’s diseases (8), colon/breast cancer (9), and cardiovascular disease (10).”
BackgroundMetal Ion Physiopathology in Neurodegenerative Disorders
Bolognin, S., Messori, L., & Zatta, P. F. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8102-1 · Cited by 169
Andersen, H. H., Johnsen, K. B., & Moos, T. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1509-8 · Cited by 151
“Hence, while important to scavenge the risks of the increasing iron for catalyzing free radicals, ferritin is simultaneously at risk of being damaged by ROS itself, which could release iron from ferritin and subsequently allow unbound iron to enter the pool of labile iron known to be chemically much more reactive than…”
BackgroundIron Homeostasis Disorder and Alzheimer’s Disease
Peng, Y., Chang, X., & Lang, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212442 · Cited by 153
“Moreover, the oxidative stress caused by iron accumulation will enhance the activity of IRP1, resulting in the enhancement of iron absorption through TfR1 and the increase in intracellular free iron level by reducing the concentration of ferritin-H and ferritin-L, which further enhances intracellular oxidative stress…”
BackgroundAmyloid Precursor Protein and Alzheimer’s Disease
Orobets, K. S., & Karamyshev, A. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914794 · Cited by 141
“Iron toxicity is connected to the generation of reactive oxygen species in the brain following oxidative stress and neuronal death [139].”
BackgroundThe effect of absorbance of Fe3+ on the detection of Fe3+ by fluorescent chemical sensors
Lohani, C. R., & Lee, K. (2009) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2009.10.004 · Cited by 139
Isobe, C., Abe, T., & Terayama, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.065 · Cited by 139
Jin, L., Wang, J., Zhao, L., Jin, H., Fei, G., Zhang, Y., Zeng, M., & Zhong, C. (2011) · Brain · doi:10.1093/brain/awq319 · Cited by 129
“Iron plays important roles in many biological processes ranging from facilitating cellular aerobic metabolism to participating in signal transduction and synthesis of neurotransmitters and DNA (Loeffler et al., 1995; Altamura and Muckenthaler, 2009).”
BackgroundMu, X., Qi, L., Dong, P., Qiao, J., Hou, J., Nie, Z., & Ma, H. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.05.019 · Cited by 128
Metal imaging in neurodegenerative diseases
Bourassa, M. W., & Miller, L. M. (2012) · Metallomics · doi:10.1039/c2mt20052j · Cited by 121
HFE Gene Variants Affect Iron in the Brain1–3
Nandar, W., & Connor, J. R. (2011) · Journal of Nutrition · doi:10.3945/jn.110.130351 · Cited by 135
“Free iron promotes Parkin and a-synuclein aggregation, thus enhancing the generation of Lewy-body, a pathological hallmark of PD (10,17,104).”
BackgroundAltamura, S., Kessler, R., Gröne, H.-J., Gretz, N., Hentze, M. W., Galy, B., & Muckenthaler, M. U. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.007 · Cited by 119
“Iron excess elicits its deleterious effects by promoting the generation of reactive oxygen species (ROS), which cause damage to proteins, DNA, and lipids (Altamura and Muckenthaler, 2009).”
BackgroundSelf-citationSong, P., Zhang, L., Long, H., Meng, M., Liu, T., Yin, Y., & Xi, R. (2017) · RSC Advances · doi:10.1039/c7ra04122e · Cited by 126
Fish-scale-derived carbon dots as efficient fluorescent nanoprobes for detection of ferric ions
Zhang, Y., Gao, Z., Yang, X., Chang, J., Liu, Z., & Jiang, K. (2019) · RSC Advances · doi:10.1039/c8ra09471c · Cited by 119
Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping
Stüber, C., Pitt, D., & Wang, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010100 · Cited by 122
“Iro acc l ti in the basal g nglia during aging is acc lerated in neurodegenerat ve di eases [2,153,154].”
BackgroundKell, D. B., & Pretorius, E. (2018) · Biological Reviews · doi:10.1111/brv.12407 · Cited by 110
“…Zein et al. (2017) Parkinson’s disease Dopamine makes substantia nigra especially sensitive; among the syndromes with the most evidence for iron involvement Altamura & Muckenthaler (2009); Barnham & Bush (2008); Berg (2007); Brar et al. (2009); Costa-Mallen et al. (2017); Crichton et al. (2011);…”
BackgroundInfluentialHuang, H. H., Li, H., Feng, J., & Wang, A. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.09.136 · Cited by 114
Yang, X., Chen, X., Lü, X., Yan, C., Xu, Y., Hang, X., Qu, J., & Liu, R. (2015) · Journal of Materials Chemistry C · doi:10.1039/c5tc02865e · Cited by 116
Pelizzoni, I., Zacchetti, D., Campanella, A., Grohovaz, F., & Codazzi, F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.007 · Cited by 111
Ji, C., & Kosman, D. J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13040 · Cited by 110
Chen, Z., Lu, D., Zhang, G., Yang, J., Dong, C., & Shuang, S. (2014) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2014.05.123 · Cited by 111
Pelizzoni, I., Macco, R., Morini, M. F., Zacchetti, D., Grohovaz, F., & Codazzi, F. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00652.x · Cited by 113
“…or pathologic alterations of its homeostasis can be the cause or a contributory cause in the neurodegeneration processes observed in many neurologic disorders (Andersen, 2004; Madsen & Gitlin, 2007; MacKenzie et al., 2008; Altamura & Muckenthaler, 2009; Benarroch, 2009; Stankiewicz & Brass, 2009).”
BackgroundMechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases
Sun, Y., Xia, X., Basnet, D., Zheng, J., Huang, J., & Liu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.904152 · Cited by 111
Increased Iron Sequestration in Alveolar Macrophages in Chronic Obtructive Pulmonary Disease
Philippot, Q., Deslée, G., Adair-Kirk, T. L., Woods, J. C., Byers, D., Conradi, S., Dury, S., Perotin, J. M., Lebargy, F., Cassan, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096285 · Cited by 97
“Perturbation from normal physiologic iron concentrations has been associated with the pathogenesis of aging, neurodegenerative disease,and cancer [1,2], presumably via the generation of excess reactive oxygen species (ROS).”
BackgroundRegulation of iron pathways in response to hypoxia
Chepelev, N. L., & Willmore, W. G. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.023 · Cited by 114
“The propensity of iron to generate ROS, inducing oxidative damage, is thought to contribute to the development and progression of some neurodegenerative diseases such as Alzheimer, Parkinson, and Huntington disease [22].”
BackgroundMRI assessment of iron deposition in multiple sclerosis
Ropele, S., de Graaf, W., Khalil, M., Wattjes, M. P., Langkammer, C., Rocca, M. A., Rovira, A., Palace, J., Barkhof, F., Filippi, M., et al. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22590 · Cited by 103
McCarthy, R. C., & Kosman, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089003 · Cited by 105
“Indeed, progressive accumulation of iron in a normal aging brain [1] or pathologic alterations of its homeostasis can be the cause of or contribute to the cellular degeneration observed in many neurologic disorders [1–4].”
BackgroundWojtunik‐Kulesza, K. A., Oniszczuk, A., & Waksmundzka‐Hajnos, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.140 · Cited by 105
McCarthy, R. C., & Kosman, D. J. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00031 · Cited by 107
“Yet, when mismanaged, iron becomes highly toxic to cells; iron-induced generation of reactive oxygen species resulting in cell death is not uncommon (Rottkamp et al., 2001; Eaton and Qian, 2002; Altamura and Muckenthaler, 2009; Anderson and Wang, 2012).”
BackgroundEryptosis as a marker of Parkinson's disease
Pretorius, E., Swanepoel, A. C., Buys, A. V., Vermeulen, N., Duim, W., & Kell, D. B. (2014) · Aging · doi:10.18632/aging.100695 · Cited by 103
“The link between prostaglandins, thromboxanes and iron accumulation in Parkinson’s disease There is extensive evidence that an overload of unliganded iron plays an important role in PD and in related disease such as progressive supranuclear palsy (PSP) [10, 22, 43, 44, 99, 107-141].”
BackgroundAltamura, S., Müdder, K., Schlotterer, A., Fleming, T., Heidenreich, E., Qiu, R., Hammes, H.-P., Nawroth, P., & Muckenthaler, M. U. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101235 · Cited by 97
“Abbreviations: CRP, C-reactive protein; DIOS, dysmetabolic iron overload syndrome; DR Resistance; IRE, Iron Responsive Element; IRP, Iron Regulatory Protein; MetS, Meta Steatohepatitis; NTBI, Non Transferrin Bound Iron; ROS, reactive oxygen species; SEM Received February 5, 2021 Revision received March 31, 2021 Accept…”
BackgroundInfluentialSelf-citationLin, Y., Epstein, D. L., & Liton, P. B. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5410 · Cited by 97
Aguirre, P., Urrutia, P. J., Tapia, V., Villa, M., Paris, I. B., Segura‐Aguilar, J., & Núñez, M. T. (2012) · BioMetals · doi:10.1007/s10534-012-9525-y · Cited by 96
Highly selective fluorescent chemosensor for detection of Fe3+ based on Fe3O4@ZnO
Li, J., Wang, Q., Guo, Z., Ma, H., Zhang, Y., Wang, B., Du, B., & Wei, Q. L. (2016) · Scientific Reports · doi:10.1038/srep23558 · Cited by 90
Could Alzheimer’s Disease Originate in the Periphery and If So How So?
Morris, G., Berk, M., Maes, M., & Puri, B. K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1092-y · Cited by 83
Hassan, A., Agamuthu, P., Ossai, I. C., & Hamid, F. S. (2020) · Biochemical Engineering Journal · doi:10.1016/j.bej.2020.107550 · Cited by 91
Copper and iron in Alzheimer's disease: a systematic review and its dietary implications
Loef, M., & Walach, H. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100376x · Cited by 95
Mitchell, E. J., Frisbie, S. H., & Sarkar, B. (2011) · Metallomics · doi:10.1039/c1mt00052g · Cited by 96
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B
Zhang, Y., Schmid, B., Nikolaisen, N. K., Rasmussen, M. A., Aldana, B. I., Agger, M. P., Calløe, K., Stummann, T. C., Larsen, H. M., Nielsen, T. T., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.01.012 · Cited by 90
“Moreover, Fe and hydrogen peroxide engage in the so-called Fenton reaction, producing ferric iron and highly reactive hydroxide, which damages DNA, proteins, and lipids in the cell (Altamura and Muckenthaler, 2009).”
BackgroundIron entry in neurons and astrocytes: a link with synaptic activity
Codazzi, F., Pelizzoni, I., Zacchetti, D., & Grohovaz, F. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00018 · Cited by 85
“, 2008), as it was suggested to occur in Alzheimer disease (Altamura and Muckenthaler, 2009).”
BackgroundAluminium and Iron in Humans: Bioaccumulation, Pathology, and Removal
Peto, M. V. (2010) · Rejuvenation Research · doi:10.1089/rej.2009.0995 · Cited by 80
“Lipid peroxidation, 94,95 and specifically Fe, 96,97 have also been thoroughly investigated as possibly contributing to the development of cardiovascular disease.”
High photoluminescent nitrogen and zinc doped carbon dots for sensing Fe3+ ions and temperature
Tammina, S. K., Yang, D., Li, X., Koppala, S., & Yang, Y. (2019) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2019.117141 · Cited by 84
Crespo, Â. C., Silva, B. D. R., Marques, L., Marcelino, E., Maruta, C., Costa, S., Timóteo, Â., Vilares, A., do Couto, F. S., Faustino, P., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.078 · Cited by 84
“…has previously been shown that protein levels of furin, which is responsible for the activation of b-secretases involved in the amyloidogenic pathway, are also modulated by iron (Altamura and Muckenthaler, 2009; Crichton et al., 2011) and possibly implicated in AD (Silvestri and Camaschella, 2008).”
BackgroundWu, X., Nawaz, S., Li, Y., & Zhang, H. (2024) · Environmental Science and Pollution Research · doi:10.1007/s11356-024-32853-6 · Cited by 81
“Irregular addition of trace elements of iron in animal feed additives can lead to dysfunction or disease in the biological organism, which includes anemia, heart disease, and liver damage (Altamura and Muckenthaler 2009; Shang-guan et al. 2017; Andreini et al. 2018).”
Weinreb, O., Amit, T., Mandel, S. A., Kupershmidt, L., & Youdim, M. B. H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2929 · Cited by 85
“WEINREB ET AL. oligodendrocytes, particularly in the selective brain regions that are targeted in neurodegenerative diseases ( e.g., cortex, hippocampus, and substantia nigra (SN) (4, 18, 253, 348, 349, 354).”
The emerging role of iron dyshomeostasis in the mitochondrial decay of aging
Xu, J., Marzetti, E., Seo, A. Y., Kim, J.-S., Prolla, T. A., & Leeuwenburgh, C. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.04.007 · Cited by 77
“…system in humans (Aquino et al., 2009) and animal models (Hahn et al., 2009) as well as in disorders such as Alzheimer’s disease (Honda et al., 2005; Altamura and Muckenthaler, 2009), Huntington’s disease (Simmons et al., 2007; Bartzokis et al., 2007), Parkinson’s disease (Lee and Andersen, 2010)…”
Li, C., Wang, Y., Zhang, X., Guo, X., Kang, X., Du, L., & Liu, Y. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.05.017 · Cited by 78
Protective effects of flavonoids and two metabolites against oxidative stress in neuronal PC12 cells
Pavlica, S., & Gebhardt, R. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.10.017 · Cited by 85
Pankaj, A., Tewari, K., Singh, S. P., & Singh, S. P. (2018) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2018.08.059 · Cited by 77
Ahmad, R., Tripathy, N., Khosla, A., Khan, M., Mishra, P., Ansari, W. A., Syed, M. A., & Hahn, Y. (2020) · Journal of The Electrochemical Society · doi:10.1149/2.0192003jes · Cited by 75
Pichler, I., Minelli, C., Sanna, S., Tanaka, T., Schwienbacher, C., Naitza, S., Porcu, E., Pattaro, C., Busonero, F., Zanon, A., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq552 · Cited by 76
“Imbalanced iron status is also associated with disorders that include diabetes mellitus (4), inflammation (5) and neurological (6) and cardiovascular diseases (7).”
BackgroundTreatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation
Aaseth, J., Alexander, J., Bjørklund, G., Hestad, K. A., Dušek, P., Roos, P. M., & Alehagen, U. (2016) · BioMetals · doi:10.1007/s10534-016-9959-8 · Cited by 79
“Copper and iron dysregulation in AD It has been reported that Fe and Cu accumulate in AD plaques, and this deposition appears to promote the progression of the Ab cascade (Altamura and Muckenthaler 2009).”
Ye, F., Wu, N. C., Li, P., Liu, Y., Li, S., & Fu, Y. (2019) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2019.117242 · Cited by 75
The pathomechanisms underlying Parkinson's disease
Jellinger, K. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.877842 · Cited by 83
Isobe, C., Abe, T., & Terayama, Y. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5333-x · Cited by 79
“With increase in ferrous iron [17], however, hydrogen peroxide generates hydroxyl radicals by the Fenton reaction.”
BackgroundPiao, Y., Lian, T., Hu, Y., Zuo, L.-J., Guo, P. F., Yu, S., Liu, L., Jin, Z. Y., Zhao, H., Li, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10593-7 · Cited by 79
Şenol, F. S., Skalicka‐Woźniak, K., Khan, M. T. H., Orhan, İ. E., Şener, B., & Głowniak, K. (2011) · Phytochemistry Letters · doi:10.1016/j.phytol.2011.08.016 · Cited by 71
Bartzokis, G., Lu, P. H., Tishler, T. A., Peters, D. G., Kosenko, A., Barrall, K. A., Finn, J. P., Villablanca, P., Laub, G., Altshuler, L. L., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1368 · Cited by 69
“The common genetic variants involved in iron absorption and metabolism (HFE and TfC2) have been reported to potentiate the risk of developing AD ([5, 27], reviewed in [28]).”
InfluentialQuintana, C., & Gutiérrez, L. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.04.012 · Cited by 73
Zhang, C., Liu, Z., Zhang, L., Zhu, A., Liao, F., Wan, J., Zhou, J. E., & Tian, Y. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202006318 · Cited by 68
Pretorius, E., Bester, J., Vermeulen, N., Lipiński, B., Gericke, G. S., & Kell, D. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085271 · Cited by 72
“heart disease, diabetes and ageing [1,2,5,18,19,54,101–110].”
Blasco, G., Puig, J., Daunis‐i‐Estadella, P., Molina, X., Xifra, G., Fernández‐Aranda, F., Pedraza, S., Ricart, W., Portero‐Otín, M., & Fernández‐Real, J. M. (2014) · Diabetes Care · doi:10.2337/dc14-0664 · Cited by 69
“This is important because BIO has recently been associated with early cognitive impairment in animal and human models (11,12).”
BackgroundAgeing neuroinflammation and neurodegeneration
Ward, R. J. (2015) · Frontiers in Bioscience · doi:10.2741/s433 · Cited by 62
Uncoupled iron homeostasis in type 2 diabetes mellitus
Altamura, S., Kopf, S., Schmidt, J., Müdder, K., da Silva, A. R., Nawroth, P. P., & Muckenthaler, M. U. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1596-3 · Cited by 67
Self-citationFernández, T., Martínez-Serrano, A., Cussó, L., Desco, M., & Ramos-Gómez, M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00260 · Cited by 65
Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project
Lehmann, D. J., Schuur, M., Warden, D. R., Hammond, N., Belbin, O., Kölsch, H., Lehmann, M. G., Wilcock, G. K., Brown, K. S., Kehoe, P. G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.018 · Cited by 68
“Excess brain iron has lso been found in other neurodegenerative conditions, such s Parkinson’s disease (Altamura and Muckenthaler, 2009; erg and Hochstrasser, 2006).”
Iron Pathophysiology in Alzheimer’s Diseases
Wang, T., Xu, S.-F., Fan, Y.-G., Li, L.-B., & Guo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_5 · Cited by 64
Neves, J., Leitz, D., Kraut, S., Brandenberger, C., Agrawal, R., Weissmann, N., Mühlfeld, C., Mall, M. A., Altamura, S., & Muckenthaler, M. U. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.036 · Cited by 64
“Excess of iron generates reactive oxygen species (ROS) that will damage proteins, lipids and DNA (Altamura and Muckenthaler, 2009; Papanikolaou and Pantopoulos, 2005).”
BackgroundSelf-citationMagnetite- and maghemite-induced different toxicity in murine alveolar macrophage cells
Park, E., Umh, H. N., Choi, D.-H., Cho, M., Choi, W., Kim, S., Kim, Y., & Kim, J. H. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1210-1 · Cited by 67
Metadata
- Authors
- Altamura, S., & Muckenthaler, M. U.
- Affiliations
- University Hospital Heidelberg (DE)
- Corresponding author
- Muckenthaler, Martina U.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-04-17
- Volume
- 16
- Issue
- 4
- Pages
- 879-895
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1785761853
- Cited by
- 369
- References
- 190
- Citations by year
- 2026: 5 · 2025: 15 · 2024: 13 · 2023: 17 · 2022: 26 · 2021: 22 · 2020: 25 · 2019: 28 · 2018: 26 · 2017: 22 · 2016: 22 · 2015: 16 · 2014: 30 · 2013: 23 · 2012: 19
- FWCI
- 17.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Baden-Württemberg Stiftung
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron toxicity, brain iron accumulation
- MeSH terms
- Aging, Alzheimer Disease, Animals, Brain, Humans, Iron, Parkinson Disease, Oxidative Stress, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.